To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.

NCT03658213 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped CTP of LARES has been out of the expire date, we are trying RWS pathway for the indication expend

Conditions

Interventions

Sponsor

AstraZeneca